Entry ID |
Data summary |
Entry Title |
Citation Title |
Authors |
50315 |
Chemical Shifts: 1 set |
ABD |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50316 |
Chemical Shifts: 1 set |
ABD12 |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50317 |
Chemical Shifts: 1 set |
ABD23 |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50318 |
Chemical Shifts: 1 set |
ABD1 |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50319 |
Chemical Shifts: 1 set |
ABD2 |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50320 |
Chemical Shifts: 1 set |
ABD3 |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50321 |
Chemical Shifts: 1 set |
ABD2' |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50322 |
Chemical Shifts: 1 set |
ABD23ss |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50323 |
Chemical Shifts: 1 set |
ABD23ac |
Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery
|
Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |